ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation—Revised 2017
Publication: Breastfeeding Medicine
Volume 12, Issue Number 5
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
2.
Maisels MJ. Managing the jaundiced newborn: A persistent challenge. CMAJ 2015;187:335–343.
3.
Preer GL, Philipp BL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed 2011;96:F461–F466.
4.
Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: A systematic review and meta-analysis. PLoS One 2015;10:e0117229.
5.
VanWagner LB, Green RM. Evaluating elevated bilirubin levels in asymptomatic adults. JAMA 2015;313:516–517.
6.
Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013;162:477–482 e471.
7.
Keren R, Luan X, Friedman S, et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008;121:e170–e179.
8.
Fouzas S, Mantagou L, Skylogianni E, et al. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics 2010;125:e52–e57.
9.
De Luca D, Romagnoli C, Tiberi E, et al. Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr 2008;97:146–150.
10.
Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol 2010;30 Suppl:S6–S15.
11.
Maisels MJ. What's in a name? Physiologic and pathologic jaundice: The conundrum of defining normal bilirubin levels in the newborn. Pediatrics 2006;118:805–807.
12.
Bertini G, Dani C, Tronchin M, et al. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001;107:E41.
13.
Dahms BB, Krauss AN, Gartner LM, et al. Breast feeding and serum bilirubin values during the first 4 days of life. J Pediatr 1973;83:1049–1054.
14.
Jangaard KA, Fell DB, Dodds L, et al. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or = 325 micromol/L (> or = 19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics 2008;122:119–124.
15.
Kaplan M, Herschel M, Hammerman C, et al. Neonatal hyperbilirubinemia in African American males: The importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr 2006;149:83–88.
16.
Kuzniewicz MW, Escobar GJ, Wi S, et al. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: A nested case-control study. J Pediatr 2008;153:234–240.
17.
Chen CF, Hsu MC, Shen CH, et al. Influence of breast-feeding on weight loss, jaundice, and waste elimination in neonates. Pediatr Neonatol 2011;52:85–92.
18.
Yang H, Wang Q, Zheng L, et al. Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of Chinese descent. PLoS One 2015;10:e0132034.
19.
Newman TB, Xiong B, Gonzales VM, et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154:1140–1147.
20.
Huang MS, Lin MC, Chen HH, et al. Risk factor analysis for late-onset neonatal hyperbilirubinemia in Taiwanese infants. Pediatr Neonatol 2009;50:261–265.
21.
Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > or = 35 weeks' gestation: An update with clarifications. Pediatrics 2009;124:1193–1198.
22.
Itoh S, Kondo M, Kusaka T, et al. Differences in transcutaneous bilirubin readings in Japanese term infants according to feeding method. Pediatr Int 2001;43:12–15.
23.
De Carvalho M, Robertson S, Klaus M. Fecal bilirubin excretion and serum bilirubin concentrations in breast-fed and bottle-fed infants. J Pediatr 1985;107:786–790.
24.
Buiter HD, Dijkstra SS, Oude Elferink RF, et al. Neonatal jaundice and stool production in breast- or formula-fed term infants. Eur J Pediatr 2008;167:501–507.
25.
Gartner LM. Breastfeeding and jaundice. J Perinatol 2001;21 Suppl 1:S25–S29.
26.
Flaherman VJ, Gay B, Scott C, et al. Randomised trial comparing hand expression with breast pumping for mothers of term newborns feeding poorly. Arch Dis Child Fetal Neonatal Ed 2012;97:F18–F23.
27.
Chapman DJ, Young S, Ferris AM, et al. Impact of breast pumping on lactogenesis stage II after cesarean delivery: A randomized clinical trial. Pediatrics 2001;107:E94.
28.
Evans KC, Evans RG, Royal R, et al. Effect of caesarean section on breast milk transfer to the normal term newborn over the first week of life. Arch Dis Child Fetal Neonatal Ed 2003;88:F380–F382.
29.
Santoro W Jr, Martinez FE, Ricco RG, et al. Colostrum ingested during the first day of life by exclusively breastfed healthy newborn infants. J Pediatr 2010;156:29–32.
30.
Aaltonen T, Alvarez Gonzalez B, Amerio S, et al. Measurement of b hadron lifetimes in exclusive decays containing a J/psi in pp collisions at radicals = 1.96 TeV. Phys Rev Lett 2011;106:121804.
31.
Saint L, Smith M, Hartmann PE. The yield and nutrient content of colostrum and milk of women from giving birth to 1 month post-partum. Br J Nutr 1984;52:87–95.
32.
Whitmer DI, Gollan JL. Mechanisms and significance of fasting and dietary hyperbilirubinemia. Semin Liver Dis 1983;3:42–51.
33.
White GL Jr, Nelson JA, Pedersen DM, et al. Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. Clin Chem 1981;27:1140–1142.
34.
Bloomer JR, Barrett PV, Rodkey FL, et al. Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterology 1971;61:479–487.
35.
Fevery J. Fasting hyperbilirubinemia: Unraveling the mechanism involved. Gastroenterology 1997;113:1798–1800.
36.
Pang WW, Hartmann PE. Initiation of human lactation: Secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia 2007;12:211–221.
37.
De Carvalho M, Klaus MH, Merkatz RB. Frequency of breast-feeding and serum bilirubin concentration. Am J Dis Child 1982;136:737–738.
38.
Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics 1990;86:171–175.
39.
Wu PY, Hodgman JE, Kirkpatrick BV, et al. Metabolic aspects of phototherapy. Pediatrics 1985;75(2 Pt 2):427–433.
40.
Davila-Grijalva H, Troya AH, Kring E, et al. How much do formula-fed infants take in the first 2 days? Clin Pediatr 2016;pii:.
41.
Sato H, Uchida T, Toyota K, et al. Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms. J Hum Genet 2015;60:35–40.
42.
Sato H, Uchida T, Toyota K, et al. Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. J Hum Genet 2013;58:7–10.
43.
Maisels MJ, Clune S, Coleman K, et al. The natural history of jaundice in predominantly breastfed infants. Pediatrics 2014;134:e340–e345.
44.
Kivlahan C, James EJ. The natural history of neonatal jaundice. Pediatrics 1984;74:364–370.
45.
American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics 2012;129:e827–e841.
46.
Verkade HJ. A novel hypothesis on the pathophysiology of neonatal jaundice. J Pediatr 2002;141:594–595.
47.
Apaydin K, Ermis B, Arasli M, et al. Cytokines in human milk and late-onset breast milk jaundice. Pediatr Int 2012;54:801–805.
48.
Uras N, Tonbul A, Karadag A, et al. Prolonged jaundice in newborns is associated with low antioxidant capacity in breast milk. Scand J Clin Lab Invest 2010;70:433–437.
49.
Bozkaya OG, Kumral A, Yesilirmak DC, et al. Prolonged unconjugated hyperbilirubinaemia associated with the haem oxygenase-1 gene promoter polymorphism. Acta Paediatr 2010;99:679–683.
50.
Zaja O, Tiljak MK, Stefanovic M, et al. Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome. J Matern Fetal Neonatal Med 2014;27:844–850.
51.
Chou HC, Chen MH, Yang HI, et al. 211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice. Pediatr Res 2011;69:170–174.
52.
Kumral A, Ozkan H, Duman N, et al. Breast milk jaundice correlates with high levels of epidermal growth factor. Pediatr Res 2009;66:218–221.
53.
Manganaro R, Marseglia L, Mami C, et al. Serum alpha-fetoprotein (AFP) levels in breastfed infants with prolonged indirect hyperbilirubinemia. Early Hum Dev 2008;84:487–490.
54.
Nagao Y, Ohsawa M, Kobayashi T. Correlation between unconjugated bilirubin and total cholesterol in the sera of 1-month-old infants. J Paediatr Child Health 2010;46:709–713.
55.
Tuzun F, Kumral A, Duman N, et al. Breast milk jaundice: Effect of bacteria present in breast milk and infant feces. J Pediatr Gastroenterol Nutr 2013;56:328–332.
56.
Watchko JF, Lin Z. Genetics of neonatal jaundice. In: Care of the Jaundiced Neonate, Stevenson DK, Maisels MJ, Watchko JF, eds. New York, NY: McGraw Hill, 2012, pp. 1–27.
57.
Chang RJ, Chou HC, Chang YH, et al. Weight loss percentage prediction of subsequent neonatal hyperbilirubinemia in exclusively breastfed neonates. Pediatr Neonatol 2012;53:41–44.
58.
Chen YJ, Chen WC, Chen CM. Risk factors for hyperbilirubinemia in breastfed term neonates. Eur J Pediatr 2012;171:167–171.
59.
Huang A, Tai BC, Wong LY, et al. Differential risk for early breastfeeding jaundice in a multi-ethnic Asian cohort. Ann Acad Med Singapore 2009;38:217–224.
60.
Huang HC, Yang HI, Chang YH, et al. Model to predict hyperbilirubinemia in healthy term and near-term newborns with exclusive breast feeding. Pediatr Neonatol 2012;53:354–358.
61.
Salas AA, Salazar J, Burgoa CV, et al. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia. BMC Pediatr 2009;9:82.
62.
Yang WC, Zhao LL, Li YC, et al. Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatr 2013;13:145.
63.
Ebbesen F, Bjerre JV, Vandborg PK. Relation between serum bilirubin levels >/ = 450 mumol/L and bilirubin encephalopathy; a Danish population-based study. Acta Paediatr 2012;101:384–389.
64.
Kuzniewicz MW, Wickremasinghe AC, Wu YW, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 2014;134:504–509.
65.
Newman TB, Kuzniewicz MW. Follow-up of extreme neonatal hyperbilirubinaemia: More reassuring results from Denmark. Dev Med Child Neurol 2015;57:314–315.
66.
Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013;74 Suppl 1:86–100.
67.
Bhutani VK, Johnson LH, Jeffrey Maisels M, et al. Kernicterus: Epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004;24:650–662.
68.
Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96(4 Pt 1):730–733.
69.
Righard L, Alade MO. Effect of delivery room routines on success of first breast-feed. Lancet 1990;336:1105–1107.
70.
Mikiel-Kostyra K, Mazur J, Boltruszko I. Effect of early skin-to-skin contact after delivery on duration of breastfeeding: A prospective cohort study. Acta Paediatr 2002;91:1301–1306.
71.
Bramson L, Lee JW, Moore E, et al. Effect of early skin-to-skin mother–infant contact during the first 3 hours following birth on exclusive breastfeeding during the maternity hospital stay. J Hum Lact 2010;26:130–137.
72.
Moore ER, Bergman N, Anderson GC, et al. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev 2016.
73.
Shekelle PG, Woolf SH, Eccles M, et al. Developing guidelines. BMJ 1999;318:593–596.
74.
Boskabadi H, Zakerihamidi M. The correlation between frequency and duration of breastfeeding and the severity of neonatal hyperbilirubinemia. J Matern Fetal Neonatal Med 2017.
75.
Dewey KG, Nommsen-Rivers LA, Heinig MJ, et al. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics 2003;112(3 Pt 1):607–619.
76.
Boies EG, Vaucher YE, The Academy of Breastfeeding Medicine. ABM Clinical Protocol #10: Breastfeeding the late preterm (34–36 6/7 weeks of gestation) and early term infants (37–38 6/7 weeks of gestation), second revision 2016. Breastfeed Med 2016;11:494–500.
77.
Kellams A, Harrel C, Omage S, et al. ABM clinical protocol #3: Supplementary feedings in the healthy term breastfed neonate. Breastfeed Med 2017;12:188–198.
78.
National Institute for Health and Care Excellence (NICE). Jaundice in Newborn Babies Under 28 Days. NICE, London, 2016.
79.
Bratlid D, Nakstad B, Hansen TW. National guidelines for treatment of jaundice in the newborn. Acta Paediatr 2011;100:499–505.
80.
Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)—Summary. Paediatr Child Health 2007;12:401–418.
81.
Flaherman VJ, Hicks KG, Cabana MD, et al. Maternal experience of interactions with providers among mothers with milk supply concern. Clin Pediatr 2012;51:778–784.
82.
Kair LR, Flaherman VJ, Newby KA, et al. The experience of breastfeeding the late preterm infant: A qualitative study. Breastfeed Med 2015;10:102–106.
83.
Hill PD. Insufficient milk supply syndrome. NAACOGS Clin Issu Perinat Womens Health Nurs 1992;3:605–612.
84.
Hill PD. The enigma of insufficient milk supply. MCN Am J Matern Child Nurs 1991;16:312–316.
85.
Lauer BJ, Spector ND. Hyperbilirubinemia in the newborn. Pediatr Rev 2011;32:341–349.
86.
Maisels MJ. Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation. Semin Fetal Neonatal Med 2010;15:129–135.
87.
Schwartz HP, Haberman BE, Ruddy RM. Hyperbilirubinemia: Current guidelines and emerging therapies. Pediatr Emerg Care 2011;27:884–889.
88.
Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: Emerging clinical insights. Pediatr Clin North Am 2009;56:671–687.
89.
Gulcan H, Tiker F, Kilicdag H. Effect of feeding type on the efficacy of phototherapy. Indian Pediatr 2007;44:32–36.
90.
Maisels MJ, Newman TB, Watchko J, et al. Phototherapy and other treatments. In: Care of the Jaundiced Neonate, Stevenson DK, Maisels MJ, Watchko JF, eds. New York: McGraw Hill, 2012, pp. 195–227.
91.
Lau SP, Fung KP. Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child 1984;59:892–894.
92.
Vogl TP, Hegyi T, Hiatt IM, et al. Intermediate phototherapy in the treatment of jaundice in the premature infant. J Pediatr 1978;92:627–630.
93.
Sachdeva M, Murki S, Oleti TP, et al. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: A randomized controlled trial. Eur J Pediatr 2015;174:177–181.
94.
de Carvalho M, Hall M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child 1981;56:568–569.
95.
Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand 1982;71:759–761.
96.
Howard CR, Howard FM, Lanphear B, et al. Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding. Pediatrics 2003;111:511–518.
97.
Gartner LM, Lee KS, Moscioni AD. Effect of milk feeding on intestinal bilirubin absorption in the rat. J Pediatr 1983;103:464–471.
98.
Flaherman VJ, Aby J, Burgos AE, et al. Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: An RCT. Pediatrics 2013;131:1059–1065.
99.
Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: A controlled trial of four interventions. Pediatrics 1993;91:470–473.
100.
Updegrove KH. Donor human milk banking: Growth, challenges, and the role of HMBANA. Breastfeed Med 2013;8:435–437.
101.
U.S. Food and Drug Administration. Use of Donor Human Milk. 2014. Available at www.fda.gov/scienceresearch/specialtopics/pediatrictherapeuticsresearch/ucm235203.htm (accessed January 25, 2014).
102.
Kair LR, Colaizy TT, Hubbard D, et al. Donor milk in the newborn nursery at the University of Iowa Children's Hospital. Breastfeed Med 2014;9:547–550.
103.
Bulpitt DW, Elmore KE, Catterton LJ. Implementing use of donor breast milk in the well baby population: It's not just for the NICU any more. J Obstet Gynecol Neonatal Nurs 2014;43(Suppl 1):S56.
104.
Brownell EA, Lussier MM, Herson VC, et al. Donor human milk bank data collection in North America: An assessment of current status and future needs. J Hum Lact 2014;30:47–53.
105.
Gourley GR, Li Z, Kreamer BL, et al. A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics 2005;116:385–391.
106.
Samra N, El Taweel A, Cadwell K. The effect of kangaroo mother care on the duration of phototherapy of infants re-admitted for neonatal jaundice. J Matern Fetal Neonatal Med 2012;25:1354–1357.
107.
Paul IM, Schaefer EW, Miller JR, et al. Weight change nomograms for the first month after birth. Pediatrics 2016;138:pii:.
References
ABM protocols expire 5 years from the date of publication.
Content of this protocol is up-to-date at the time of publication. Evidence based revisions are made within 5 years or sooner if there are significant changes in the evidence.
The first version of this protocol was authored by Lawrence Gartner.
Information & Authors
Information
Published In
Copyright
Copyright 2017, Mary Ann Liebert, Inc.
History
Published in print: June 2017
Published online: 1 June 2017
Published ahead of print: 10 April 2017
Topics
Authors
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.